Clinical, Microbiological, and Economic Benefit of a Change in Antibiotic Prophylaxis for Cardiac Surgery
2002 ◽
Vol 23
(7)
◽
pp. 402-404
◽
Keyword(s):
AbstractVancomycin and rifampicin replaced cephazolin as antibiotic prophylaxis for coronary artery bypass surgery at our institution. Following this intervention, there was a significant decrease (P< .001) in the surgical-site infection rate from 10.5 (95% confidence interval, 8.2 to 13.3) to 4.9 (95% confidence interval, 3.2 to 7.1) infections per 100 procedures. An estimated $576,655 (Australian) was saved between two 12-month periods.
2016 ◽
Vol 8
(3)
◽
pp. E197-E199
◽
Keyword(s):
1997 ◽
Vol 37
(3)
◽
pp. 237-247
◽
2014 ◽
Vol 3
◽
pp. 252-256
◽
2008 ◽
Vol 17
(2)
◽
pp. 133-140
◽